Insulet (PODD) excels with strong Q2 results, Omnipod 5 app launch, and >20% growth outlook. Read here for an investment ...

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...

Ondas (ONDS) priced a public offering of 46.16 million shares at $3.25 each, aiming to raise $150 million before expenses.

What Happened? A number of stocks jumped in the afternoon session after cooler-than-expected inflation data ignited investor ...

What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report ...

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat moderate to severe obstructive sleep apnea (OSA). The Belgium-based medtech firm ...

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...

Guardant Health (NASDAQ:GH), a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025.

Consolidated Adjusted Net Income Attributable to Bausch Health (non-GAAP)1 Consolidated Adjusted net income attributable to Bausch Health (non-GAAP)1 for the second quarter of 2025 was $335 ...